Showing results (51-60 of 250) with videos related to
Sort By:
Pageof 25
Leukemia|August 26, 2025
The evolving nosology of myeloid neoplasms: the semi-centennial of the 1976 French-American-British classificationShyam A Patel, John M BennettCurrent Hematology Reports|May 4, 2005
The clinical implications of the World Health Organization's classification of myelodysplastic syndromesRami S Komrokji, John M BennettLeukemia & Lymphoma|January 3, 2013
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT studyFrancine M Foss, Nelida Sjak-Shie, Andre Goy, et al.American Family Physician|March 23, 2007
Iron deficiency anemiaShersten Killip, John M Bennett, Mara D ChambersHematology/Oncology Clinics of North America|April 3, 2010
Myelodysplastic syndromes classification and risk stratificationRami S Komrokji, Ling Zhang, John M BennettClinical Lymphoma, Myeloma & Leukemia|March 4, 2022
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative NeoplasmsFranco Castillo Tokumori, Najla Al Ali, Onyee Chan, et al.Clinical Lymphoma, Myeloma & Leukemia|August 12, 2020
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in MyelofibrosisFranco Castillo-Tokumori, Chetasi Talati, Najla Al Ali, et al.Leukemia Research Reports|December 28, 2013
Hemophagocytic lymphohistiocytosis masquerading as progressive chronic lymphocytic leukemiaDeepak Kilari, Nicholas Venci, Jonathan Friedberg, et al.Leukemia Research|September 4, 2018
Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemiaChad A Hudson, W Richard Burack, John M BennettCell Chemical Biology|July 30, 2020
Strategies for Tuning the Selectivity of Chemical Probes that Target Serine HydrolasesFranco Faucher, John M Bennett, Matthew Bogyo, et al.Pageof 25